Your session is about to expire
← Back to Search
Behavioural Intervention
MedBIKE for Hypoplastic Left Heart Syndrome (MedBike Trial)
N/A
Waitlist Available
Led By Nee Khoo, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
single ventricle patients with Fontan circulation
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre- vo2 max performed 1 week before 24 hiit exercise sessions and within 1 week after last session
Awards & highlights
MedBike Trial Summary
This trial will test if a new rehabilitation program using technology can help people with a certain heart condition.
Eligible Conditions
- Hypoplastic Left Heart Syndrome
- Congenital Heart Defects
- Physical Activity
MedBike Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMedBike Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre- vo2 max performed 1 week before 24 hiit exercise sessions and within 1 week after last session
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre- vo2 max performed 1 week before 24 hiit exercise sessions and within 1 week after last session
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Exercise capacity
Secondary outcome measures
Number of participants with exercise program specific adverse events
Qualitative interviews to determine the perception of exercise in CHD patient
MedBike Trial Design
1Treatment groups
Experimental Treatment
Group I: HIIT Exercise ProgramExperimental Treatment1 Intervention
Exercise on a MedBIKE 3 times a week for 8 weeks with pre- and post-CPET testing, questionnaires and qualitative interviews.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MedBIKE
2019
N/A
~20
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
884 Previous Clinical Trials
393,225 Total Patients Enrolled
2 Trials studying Hypoplastic Left Heart Syndrome
22 Patients Enrolled for Hypoplastic Left Heart Syndrome
Nee Khoo, MDPrincipal InvestigatorUniversity of Alberta
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger